. Stanley-fahn-lecture, The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered, Mov Disord, vol.21, issue.12, pp.2042-51, 2005.

M. , D. D. , L. J. , E. M. , and O. Feldman-h, Dementia with Lewy bodies: diagnosis and management: Third report of the DLB Consortium, Neurology, vol.65, pp.1863-72, 2005.

H. , E. C. Mouatt, A. Faucheux, B. Bonnet, A. M. Javoy-agid et al., Dopamine, tremor and Parkinson's disease, Lancet, vol.340, issue.-, pp.125-126, 1992.

O. J. Rodriguez-oroz-m and . G. Goetz-c, Missing pieces in the Parkinson's disease puzzle, Nat Med, vol.16, pp.653-61, 2010.

S. , J. Mena, N. Hunot, and S. , Divalent Metal Transporter 1 (DMT1) contributes to neurodegeneration in parkinsonian syndromes, Proc. Natl Acad. Sci. U.S.A, vol.105, pp.18578-18583, 2008.

S. J. and A. E. Brundin-p, -A deadly spread: cellular mechanisms of ?synuclein transfer, Cell Death Differ, vol.18, pp.1425-1433, 2011.

A. P. Vyas-s and . F. Javoy, Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease, Histol. and Histopathol, vol.25, pp.12-31, 1997.

H. E. Hunot-s, -Neuroinflammation in Parkinson's disease: a target for neuroprotection? Lancet Neurol, pp.382-397, 2009.

N. T. Mogi-m and I. H. Togari-a, -Changes in cytokines and neurotrophins in Parkinson's disease, J Neural Transm, vol.60, pp.277-290, 2000.

R. A. Stone-d, . L. Mosley-r, and . E. Gendelman-h, -Nitrated {alpha}-synuclein-induced alterations in microglial immunity are regulated by CD4+ T cell subsets, J. Immunol, vol.182, pp.4137-4149, 2009.
URL : https://hal.archives-ouvertes.fr/in2p3-00608259

R. and H. S. Herrero-m, Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism

K. P. , O. , S. S. Holton-j, and R. T. Lees-a, Relationships between age and late progression of Parkinson's disease: a clinico-pathological study, Brain, vol.133, pp.1755-1762, 2010.

Y. Hoehn-m, Parkinsonism: onset, progression, and mortality, Neurology, vol.17, issue.5, pp.427-442, 1967.
DOI : 10.1212/WNL.17.5.427

L. I. Ruiz-p, P. S. Del, and . S. Bernardos-v, -Motor complications in Parkinson's disease: ten year follow-up study, Mov Disord, vol.25, pp.2735-2739, 2010.
URL : https://hal.archives-ouvertes.fr/in2p3-00025670

K. C. and G. D. Bernard-fa, Cholinergic mesencephalic neurons are involved in gait and postural disorders in parkinsonian patients and monkeys, J. Clin. Invest, vol.120, pp.2745-54, 2010.

H. E. and G. A. Duyckaerts-c, -Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson's disease and in progressive supranuclear palsy, Proc. Natl. Acad. Sci. U.S.A, vol.84, pp.5976-5980, 1987.
URL : https://hal.archives-ouvertes.fr/hal-00840181

M. P. Lozano-a and . Stanzione-p, Implantation of human pedunculopontine nucleus: a safe and clinically relevant target in Parkinson's disease, Neuroreport, vol.16, pp.1877-1881, 2005.

F. M. Debû-b and . Fraix-v, Subthalamic nucleus versus pedunculopontine nucleus stimulation in Parkinson disease: synergy or antagonism?, J Neural Transm, vol.118, pp.1469-1475, 2011.